8 May 2017 16:17
8 May 2017
Craven House Capital Plc
("Craven House" or the "Company")
Issue of Equity
The Company announces that Balbir Bindra has been issued 2,316 new ordinary shares of $1.00 each and Calum Morrison has been awarded 2,452 new ordinary shares of $1.00 each of as per the terms of their respective appointment letters. Alexandra Eavis has been issued 4,768 new ordinary shares of $1.00 each in lieu of directors fees and notice period relating to her resignation in February 2016.
Mr. Evan Kalimtgis has been issued 14,420 shares in lieu of interest payments outstanding in relation to loans provided to the Company. Wise Star Capital Investment Ltd have been issued 10,720 shares in lieu of principal and interest outstanding on loans made to the Company.
Application will be made for the new ordinary shares, which will rank pari passu with the existing ordinary shares in the Company, to be admitted to trading on AIM. It is expected that Admission will become effective and dealings will commence at 8.00 a.m. on 12 May 2017.
Following Admission the total issued share capital will consist of 2,499,038 ordinary shares. As such the total number of voting rights in the Company will be 2,499,038 ordinary shares. This number may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.
~ Ends ~
For further information please contact:
Craven House Capital Plc Mark Pajak www.Cravenhousecapital.com
| Tel: 0203 286 8130
|
SI Capital Broker Nick Emerson www.sicapital.co.uk | Tel: 01483 413500 |
SPARK Advisory Partners Limited Nominated Adviser Matt Davis/Mark Brady www.Sparkadvisorypartners.com |
Tel: 0203 368 3550
|
About Craven House Capital:
Craven House Capital is a frontier and emerging market focused merchant bank seeking value oriented long term investments. Craven House invests in all segments of the capital structure in partnership with local entrepreneurs and the local business community. Craven House provides long term patient capital and is often involved in restructuring, expansion and turn around investments in crisis and transitioning economies.
This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.
1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||
a)
| Name
| Balbir Bindra
| |||
2
| Reason for the notification
| ||||
a)
| Position/status
| Non-Executive Director
| |||
b)
| Initial notification /Amendment
| Initial notification | |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
a)
| Name
| Craven House Capital PLC | |||
b)
| LEI
|
| |||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||||
a)
| Description of the financial instrument, type of instrument | Ordinary shares of USD 1.00 each
| |||
|
| ||||
Identification code | GB00BD4FQ360 | ||||
|
| ||||
b)
| Nature of the transaction
| Director remuneration as per letter of appointment | |||
c)
| Price(s) and volume(s) |
|
|
|
|
|
| Price(s) | Volume(s) |
| |
|
| Nil | 2,316 |
| |
|
|
|
|
| |
d)
| Aggregated information |
| |||
|
| ||||
- Aggregated volume | 2,316 | ||||
|
| ||||
- Price | Nil | ||||
|
| ||||
e)
| Date of the transaction
| 8 May 2017 | |||
f)
| Place of the transaction
| London Stock Exchange, AIM
| |||
1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||
a)
| Name
| Calum Morrison
| |||
2
| Reason for the notification
| ||||
a)
| Position/status
| Non-Executive Director
| |||
b)
| Initial notification /Amendment
| Initial notification | |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
a)
| Name
| Craven House Capital PLC | |||
b)
| LEI
|
| |||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||||
a)
| Description of the financial instrument, type of instrument | Ordinary shares of USD 1.00 each
| |||
|
| ||||
Identification code | GB00BD4FQ360 | ||||
|
| ||||
b)
| Nature of the transaction
| Director remuneration as per letter of appointment | |||
c)
| Price(s) and volume(s) |
|
|
|
|
|
| Price(s) | Volume(s) |
| |
|
| Nil | 2,452 |
| |
|
|
|
|
| |
d)
| Aggregated information |
| |||
|
| ||||
- Aggregated volume | 2,452 | ||||
|
| ||||
- Price | Nil | ||||
|
| ||||
e)
| Date of the transaction
| 8 May 2017 | |||
f)
| Place of the transaction
| London Stock Exchange, AIM | |||
Craven House Capital (CRV)